Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-09-18
2007-09-18
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S597000, C514S651000, C514S652000, C562S470000, C564S051000, C564S165000, C564S348000
Reexamination Certificate
active
10512232
ABSTRACT:
The present invention relates to novel compounds of formula (I),or a salt, solvate, or physiologically functional derivative thereof, to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
REFERENCES:
patent: 4627432 (1986-12-01), Newell et al.
patent: 4778054 (1988-10-01), Newell et al.
patent: 4811731 (1989-03-01), Newell et al.
patent: 5035237 (1991-07-01), Newell et al.
patent: 5552438 (1996-09-01), Christensen, IV
patent: 5590645 (1997-01-01), Davies et al.
patent: 5873360 (1999-02-01), Davies et al.
patent: 3513885 (1985-10-01), None
patent: 0069715 (1983-01-01), None
patent: 0947498 (1999-10-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2140800 (1984-12-01), None
patent: 2 159 151 (1985-11-01), None
patent: 2159151 (1985-11-01), None
patent: 2169265 (1986-07-01), None
patent: 2178965 (1987-02-01), None
patent: 2242134 (1991-09-01), None
patent: 10152460 (1998-06-01), None
patent: WO99/16766 (1999-04-01), None
patent: WO99/47505 (1999-09-01), None
patent: WO 01/13953 (2001-03-01), None
Ramsay et al, “Polymorphism in the β2-adrenorecptor gene are associated with decreased airway responsiveness,” Clinical and Experimental Allergy, 1999 vol. 29, pp. 1195-1203.
MedlinePlus Drug Information: Salmeterol Oral Inhalation (2007), available at: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a695001.html.
Fuji et al., “Novel phosphodiesterase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen,”The Journal of Pharmacology and Experimental Theapeutics284(1):162-169 (1998).
Landells et al., “Oral administration of the phosphodiesterase (PDE)4 inhibitor, V11294A inhibits ex-vivo agonist-induced cell activation,”Eur Resp J.12(Suppl. 28):Abst. P2393 CAS reference No. 162401-32-3 (Sep. 19-23, 1998).
Box Philip Charles
Coe Diane Mary
Looker Brian Edgar
Procopiou Panayiotis Alexandrou
Anderson Rebecca
Freistein Andrew B.
Glaxo Group Limited
Smith Robert J.
LandOfFree
Phenethanolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenethanolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenethanolamine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773608